BioMed Research International / 2015 / Article / Fig 1

Research Article

Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma

Figure 1

Kaplan-Meier survival curves demonstrated an overall survival benefit of cytosolic ERβ expression in LAC patients. (a, b) Both nuclear and cytosolic ERα expression revealed no significant difference in overall survival in advanced LAC patients. (c, d) Nuclear ERβ expression exhibited little overall survival benefit in patients. However, cytosolic expression of ERβ exhibited better overall survival in advanced LAC patients (). (e, f) Representative immunohistochemistry staining images of nuclear and cytosolic ERβ in patient number S13-1555 at lower (400x; (e)) and higher (1000x; (f)) magnification. (g, h) Representative immunohistochemistry staining images of cytosolic ERβ in patient number S10-5378 at lower (400x; (g)) and higher (1000x; (h)) magnification.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.